BioPharm International - May 2022

BioPharm International- May 2022

Issue link: https://www.e-digitaleditions.com/i/1467950

Contents of this Issue

Navigation

Page 34 of 35

www.biopharminternational.com May 2022 eBook BioPharm International 35 REFERENCES 1. Merck KGaA, "Acquisition of Exelead Completed, Plans to Invest More Than € 500 Million in Technology Scale-Up," Press Release, Feb. 23, 2022. 2. Catalent, "Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe," Press Release, April 6, 2022. 3. Recipharm, "Recipharm Acquires GenIbet to Bolster Biologics Offering," Press Release, Feb. 1, 2022. 4. Recipharm, "Recipharm Expands its Advanced Therapy Medicinal Products (ATMPs) Offering Into Virotherapies With the Acquisition of Vibalogics," Press Release, Feb. 18, 2022. 5. Recipharm, "Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the US," Press Release, Feb. 18, 2022. 6. Samsung Biologics, "Samsung Biologics Reaches Agreement with Biogen to Acquire Full Ownership of Samsung Bioepis," Press Release, Jan. 27, 2022. 7. FDA, "FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes," Press Release, July 28, 2021. 8. FDA, "FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira," Press Release, Oct. 18, 2021. 9. FDA, "FDA Approves First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions," Press Release, Sep. 17, 2021. 10. ten23 health, "Launch of ten23 health – Opening a New Chapter in Contract Pharmaceutical Development and Manufacturing Services," Press Release, Sep. 1, 2021. 11. ten23 health, "Swissfillon, a Leader in Sterile Filling of Complex Pharmaceuticals, Joins ten23 health and Enhances the Combined Company's Integrated Offering to Its Customers," Press Release, Oct. 25, 2021. 12. Fujifilm Diosynth Biotechnologies, "Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.," Press Release, Jan. 26, 2022. 13. Fujifilm Diosynth Biotechnologies, "FUJIFILM Diosynth Biotechnologies Doubles its Existing Laboratory Footprint in North Carolina," Press Release, Jan. 5, 2022. BP Partnerships for Outsourcing Industry Update SUBSCRIBE AT BIOPHARMINTERNATIONAL.COM Science & Business eBulletin News and insights about technology and regulatory issues, company changes, company updates, and conference coverage. First Look Previews the latest issue of BioPharm International ® with links to online content and the digital edition of the magazine. BioPharma Knowledge Resource Build your biopharma development and manufacturing knowledge base with the latest whitepapers, application notes, posters, and other educational resources from biopharma industry suppliers. in the biopharmaceutical industry delivered straight to your inbox by signing up. Get the latest news, research, and trends Ajinomoto Bio-Pharma Services .................................................................... 19 BioVectra DCL ................................................................................................... 15 Curia ..................................................................................................................... 2 Emergent BioSolutions .................................................................................... 11 Entegris ..............................................................................................................29 Eurofins Lancaster Laboratories ...................................................................... 5 G-CON Manufacturing .....................................................................................25 Intertek Asg (Darts) ..........................................................................................21 Sartorius Stedim North America Inc ............................................................... 9 Ad Index COMPANY PAGE

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - May 2022 - BioPharm International- May 2022